Long-term Consequences of Admission for Pediatric Intensive Care Before One Year of Age

November 14, 2023 updated by: Gorm Greisen, Rigshospitalet, Denmark

This study is a retrospective cohort study. The PICU children will include all surviving children who were admitted to the PICU of Copenhagen University Hospital between 1st of January 2002 and 31st of December 2016.

A link to a questionnaire including the Strengths-and-Difficulties parental questionnaire evaluating neurodevelopmental- and behavioral impartment as well as question on current impairments and health, will be sent to parents. For the children aged between 11 and 17 years an additional self-rated questionnaire will be provided.

Study Overview

Detailed Description

This study is a retrospective cohort study. The PICU children will include all surviving children who were admitted to the pediatric intensive care section of the Department of Neonatology of Copenhagen University Hospital between 1st of January 2002 and 31st of December 2016.

The Strengths-and-Difficulties parental questionnaire evaluating neurodevelopmental- and behavioral impartment is web-based an hosted on a safe hospital server. The link will be sent to the universat digital post-box that all Danish citizens use for contact to the public authorities. For the children aged between 11 and 17 years an additional self-rated questionnaire will be provided. Furthermore, parents will answer questions on chronic illness, motor and sensory handicap, and special pedagogical support in day care institutions and school.

Study Type

Observational

Enrollment (Actual)

330

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Gorm Greisen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children and adolescents

Description

Inclusion Criteria:

  • Admitted to the PICU of Copenhagen University Hospital between 1st January 2002 to 31st of December 2016
  • Age of admission > 28 days, if born > 37 + 0 or have reached the gestational age of > 40 weeks if the child is premature.
  • Needing ≥ 2 days ventilator support during the PICU stay
  • Valid civil registration number

Exlusion criteria:

- Death before follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pediatric intensive care
Children admitted to a pediatric intensive care unit before one year of age and admitted for to days or more and treated with mechanical ventilation and alive at follow
admission to pediatric intensive care with mechanical ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total difficulty score of the SDQ questionnaire
Time Frame: 2 to 18 years of age
Total difficulty score of the Strengths and Difficulties Questionnaire
2 to 18 years of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of cerebral palsy
Time Frame: 2 to 18 years of age
cerebral palsy defined as 2 or higher on the GMFCS-scale
2 to 18 years of age

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of learning disability
Time Frame: 2 to 18 years of age
any educational or pedagogical support as reported by parents, more than 9 hours per week
2 to 18 years of age
Rate of chronic disease
Time Frame: 2-18 years
any disease requiring continued medication and/or medical check-ups
2-18 years
Rate of visual impairment
Time Frame: 2-18 years
that cannot be corrected by glasses or blind
2-18 years
Rate of hearing impairment
Time Frame: 2-18 years
requiring amplification by hearing aid or deaf
2-18 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: gorm greisen, prof, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2020

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

September 15, 2020

First Submitted That Met QC Criteria

September 23, 2020

First Posted (Actual)

September 24, 2020

Study Record Updates

Last Update Posted (Estimated)

November 16, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VD-2019-47

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Complex personal data, that cannot meaningfully be reduced to a level that will make re-identification possible

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurodevelopmental Disorders

Clinical Trials on admission to pediatric intensive care with mechanical ventilation

3
Subscribe